Catechol-O -methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis
- 1 June 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Psychiatric Genetics
- Vol. 11 (2) , 105-109
- https://doi.org/10.1097/00041444-200106000-00009
Abstract
Catechol-O -methyltransferase (COMT) gene has long been implicated to play a role in the pathogenesis of schizophrenia. The aim of this study is to assess the relationship of schizophrenia and its subgroups with COMT gene polymorphism. We have attempted to evaluate a possible correlation between the severity and prognosis of the illness (the psychopathology of symptoms) and COMT gene polymorphisms. The study comprised 129 unrelated subjects who strictly met DSM-IV criteria for schizophrenia, and 65 healthy unrelated controls. All subjects were of Turkish origin. A clinical evaluation of all patients was accomplished by applying the Brief Psychiatric Rating Scale (BPRS) test. The analysis of COMT polymorphism was performed using the polymerase chain reaction technique. Regarding COMT gene polymorphisms, no statistically significant difference was found between schizophrenic patients and control subjects. However, within the schizophrenic group, the average of BPRS points of patients with the L/L genotype was significantly higher than those of the L/H and H/H genotypes (F = 6.25, degrees of freedom = 2, P = 0.003). Although no statistically significant difference was found between the duration of illness and COMT variations, a higher frequency of hospitalization was found in patients with the L/L genotype compared with other groups (t = 3.048, P = 0.003). In conclusion, the findings indicate that COMT gene polymorphisms were not statistically significant between patient and control groups. However, the patients with the L/L genotype may have much more severe clinical signs in Turkish schizophrenics. COMT variations, however, do not help to evaluate the susceptibility of the patients, but can help in the estimation of severity of clinical manifestations. Further studies are required to better understand the association of symptomatology of schizophrenia and other psychiatric disorders with COMT gene polymorphism.Keywords
This publication has 16 references indexed in Scilit:
- Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behaviorAmerican Journal of Medical Genetics, 2000
- Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophreniaBiological Psychiatry, 1997
- Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in FinlandPharmacogenetics, 1997
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disordersAmerican Journal of Psychiatry, 1995
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988
- The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significanceActa Psychiatrica Scandinavica, 1987
- Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illnessActa Psychiatrica Scandinavica, 1983
- Catechol-O-methyltransferase of erythrocytes in patients with endogenous psychosesPsychiatry Research, 1981
- THE BRIEF PSYCHIATRIC RATING SCALEPsychological Reports, 1962